Piqray User Reviews & Ratings
Piqray has an average rating of 7.4 out of 10 from a total of 5 reviews on Drugs.com. 80% of reviewers reported a positive experience, while 20% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Breast Cancer | 5 reviews for Breast Cancer | 82 medications |
- Car...
- Taken for 2 to 5 years
- June 26, 2024
For Breast Cancer "I’ve been taking Piqray for four years. My original daily dose was 300 mg and then reduced to 250 mg because it caused me to become diabetic and have problems maintaining a proper A1c. (I’m on three diabetes drugs now.) Other side effects have mostly been quite tolerable and not as bad as I expected. Nausea doesn’t occur much anymore. Diarrhea has been more of a problem and flares occasionally. I’m tired most of the time and my energy level has decreased and never seems what it was before. My tastes have been affected, and there are days I have no appetite. My concentration has changed, and I have a “foggy” brain at times. Piqray is easy to take and has become a part of my life. My regular PET scans show I’m still in remission. I walk two miles four to five days each week, and I keep grandkids 16-24 hours each week. Piqray, in spite of the above side effects, is allowing me to have a decent quality of life!"
- Leg...
- Taken for 6 months to 1 year
- April 23, 2021
For Breast Cancer "I have metastatic stage IV breast cancer, and Piqray left me with 24-hour nausea; a nausea that was so severe I lost 30 lb and could not eat or drink. I was so ill that I actually wanted to die, and it was when my refills were delayed that I found myself feeling better and better with minimal nausea. I did take one dose when my Rx came, and I was back to 24-hour nausea. I then made the decision to stop the Piqray then and have not looked back. Piqray was making me worse than my cancer."
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Frequently asked questions
- Cat...
- Taken for 1 to 6 months
- September 29, 2021
For Breast Cancer "MBC to bone, spine. Taking Ibrance for 6 years. Piqray has side effects like every cancer medication. Doctor was very adamant in letting them know if side effects became worse, so they could change dosage. Worst side effect would be to have my cancer grow. So, I deal with diarrhea, sores in mouth, diabetes, fatigue. Let your oncologist know, so they could help with the medications. It’s the only way to prevent cancer."
- Jan...
- Taken for 1 to 2 years
- July 29, 2024
For Breast Cancer "Piqray is a good medicine for metastatic breast cancer. It makes me feel normal."
Are you taking this medicine?
Your review helps others make informed decisions.More about Piqray (alpelisib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
For Breast Cancer "On 300mg for 10 months. Only noticeable side effects are dry hands and feet and hair thinning. Multiple metastatic lesions (brain, spine, liver, omentum) have shrunk on Piqray. CA15-3 has gone from 3,200 to 340 while on this drug."